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Abstract 
Cluster analysis aims at separating patients into phenotypical-
ly heterogenous groups and defining therapeutically homoge-
neous patient subclasses. It is an important approach in data-
driven disease classification and subtyping. Acute coronary 
syndrome (ACS) is a syndrome due to sudden decrease of cor-
onary artery blood flow, where disease classification would 
help to inform therapeutic strategies and provide prognostic 
insights. Here we conducted outcome-driven cluster analysis 
of ACS patients, which jointly considers treatment and patient 
outcome as indicators for patient state. Multi-task neural net-
work with attention was used as a modeling framework, in-
cluding learning of the patient state, cluster analysis, and fea-
ture importance profiling. Seven patient clusters were discov-
ered. The clusters have different characteristics, as well as 
different risk profiles to the outcome of in-hospital major ad-
verse cardiac events. The results demonstrate cluster analysis 
using outcome-driven multi-task neural network as promising 
for patient classification and subtyping. 
Keywords:  
Cluster Analysis, Acute Coronary Syndrome, Neural Net-
works (Computer) 
Introduction 
Precision medicine is a healthcare approach which aims at 
developing more effective ways to improve health and treat 
disease by taking individual traits into account [1]. One at-
tempt toward precision medicine is to provide the best availa-
ble care for patients based on their disease subtypes within a 
disease of common biological basis. Patient cluster analysis 
comprises a solid step towards precision medicine, which ful-
fils the task of disease classification and subtyping [2]. Cluster 
analysis has been used for subgroup analysis of type 2 diabe-
tes [3], accurate phenotyping of heart failure and related syn-
dromes [4,5], as well as identifying meaningful patient clus-
ters for developing specific treatment programs  in geriatric 
stroke patients [6]. The results support cluster analysis as a 
useful tool to discover disease classes and subtypes, which can 
inform therapeutic strategies like individualizing treatment 
regimens and providing prognosis insights. 
Cluster analysis is performed based on a similarity or distance 
measure. Commonly used similarity measures include Euclid-
ean distance, cosine similarity, Jaccard similarity, and so on. 
Traditionally, as no associating outcome measure is available 
for cluster analysis, the methods are unsupervised, and thus 
the similarity measure takes all patient characteristics as 
equally important, the results of which are less desired when 
we target the clustering results at reflecting specific patient 
traits. It has been recognized that patient similarities for clus-
ter analysis are commonly context-based and are sometimes 
associated with clinical outcomes of interest. Outcome-driven 
clustering (sometimes referred to as ‘semi-supervised cluster-
ing’ or ‘supervised clustering’) is applied when outcome 
measures are available and can serve as a noisy surrogate for 
the (unobserved) target cluster [7], which has been proven 
useful in patient cluster analysis for precision cohort finding 
[8] and clinical decision support [9]. 
Neural network has been increasingly used as a successful 
data modeling paradigm, which solves tasks such as pattern 
recognition and classification through a learning process and 
has been recently used in medical informatics research for 
representation learning [10]. Multi-task learning is a strategy 
where multiple learning tasks are solved at the same time to 
benefit from their commonalities and contrasts. Neural net-
works adapt to multi-task learning intuitively by designing 
specific network structure and cost function [11]. Though use-
ful, neural network is often criticized for lack of interpretabil-
ity. Attention mechanism is thus introduced to neural network 
increase model interpretability as well as performance [12] 
and has been applied to healthcare research [13]. Thus, a joint 
use of the three techniques would facilitate representation 
learning leveraging information from different tasks in an in-
terpretable manner. 
Acute coronary syndrome (ACS) is a syndrome due to sudden 
decreased coronary artery blood flow. A treatment objective 
of ACS is to prevent major adverse cardiac events (MACE) 
during hospitalization. ACS can be classified into ST eleva-
tion myocardial infarction (STEMI), non-ST elevation myo-
cardial infarction (NSTEMI), and unstable angina (UA) by 
cardiac marker and manifestation of ST-elevation in electro-
cardiogram. However, exploration of biomarkers for disease 
classification and subtyping has never stopped [14,15]. In this 
study, we presented outcome-driven clustering of ACS pa-
tients based on biomarkers as well as clinical indicators. We 
desired using patient state (which is an abstract characteriza-
tion of patient traits regarding the disease) for clustering and 
decided on four outcome measures as surrogates to indicate 
the patient state: antiplatelet treatment, beta-blockers treat-
ment, statins treatment, and in-hospital MACE. The four 
measures are supposed to reflect different facets of the patient 
state. Therefore, a joint consideration would enable a more 
comprehensive and targeted depiction of the patient state. 
Cluster analysis has been conducted on ACS patients to dis-
cover symptom clusters [16], assess the differences in mortali-
ty between symptom clusters [17], discover clusters of differ-
ent lifestyle risk factors [18], and to detect critical patients 
using medical parameter time series [19]. However, all the 
above studies are unsupervised and none of them use neural 
network as the modeling framework. 
In this study, we conducted outcome-driven patient clustering 
on hospitalized ACS patients, identified underlying patient 
clusters, and profiled the cluster characteristics, especially risk 
factors to in-hospital MACE. Novelty of our study includes: 
(1) using outcome-driven cluster analysis to guide cluster 
analysis; (2) using multi-task neural network to learn a multi-
faceted representation of patient characteristics; and (3) atten-
tion mechanism was introduced to the neural network model 
to increase model interpretability and facilitate feature im-
portance profiling. 
Methods 
Cohort construction 
The multi-center retrospective cohort study was conducted at 
38 urban and rural hospitals in China. Adult hospitalized 
patients (aged ≥18 years) with a final diagnosis of ACS 
identified at the time of death or discharge were included. 
Each hospital enrolled the first five consecutive patients on a 
monthly basis from January 1, 2008 through December 31, 
2015. We excluded patients who: (1) had potentially lethal 
diseases (e.g., incurable cancer, decompensated cirrhosis, 
multisystem organ failure); (2) had an expected life span 
below 12 months; or (3) died within 10 minutes of arrival at 
the hospital. A patient needs to have age, gender, ACS type 
recorded to be included in the analysis. A total of 26,986 pa-
tients were included in this study. 
Feature construction 
Patient data was identified and reviewed by trained investiga-
tors to record clinical information. We included 41 patient 
characteristics as features, including: disease types (ACS type 
and Killip class), demographics, personal disease history, 
comorbidities, habits, laboratory test results, and procedures. 
Data outliers determined based on clinical knowledge were 
removed and represented as missing data. Missing values were 
imputed by multiple imputation utilizing the ‘mice’ package in 
R [20]: continuous variables by predictive mean matching, 
binary variables by logistic regression, and a proportional 
odds model for ordinal variables. We conducted one-hot en-
coding on categorical variables with more than two categories, 
and standardized continuous values by removing the mean and 
scaling to unit variance. 
Classification with multi-task neural network model 
Multi-task neural network with attention was used as the 
framework. A schematic representation of the neural network 
design is shown in Figure 1. The attention layer was imple-
mented as a hidden layer with softmax activation, with the 
same number of nodes as the shared input layer. Attention was 
added to the attention layer by multiplying element-wise with 
the shared input layer. 
 
Figure 1 - Illustration of the neural network design. 
 
Following the shared input layer are hidden layers, then a rep-
resentation layer which learns a joint patient representation. 
The four classification tasks are optimized simultaneously. For 
each task, the input for the task was formed by concatenating 
the representation layer with the features in the shared input 
layer after adding attention to each feature. It then reaches the 
final output layer after adding hidden layers in between. 
During training, features mentioned in the ‘Feature construc-
tion’ section were used as input for in the shared input layers, 
and the ground truth of the four patient traits (MACE, an-
tiplatelet treatment, beta-blockers treatment, and statins treat-
ment) were used as output in the four output layers for each 
task. 
Binary cross entropy loss was used for each classification task. 
For task j (j in 1, 2, 3, and 4), the task weight is denoted as 𝑤𝑗 , 
the ground truth and predicted probability for an instance i are 
denoted as 𝑦𝑖𝑗  and 𝑦𝑖?̂? respectively, and 𝐻(𝑦𝑖𝑗 , 𝑦𝑖?̂?) is the bina-
ry cross entropy loss. The cost function for neural network we 
used is defined as: 
C ≜
1
𝑛
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where n is the number of training samples. In our experiments, 
we assigned equal weight to all classification tasks. 
Parameters were optimized using ‘Adam’. Training was con-
ducted with a batch size of 512 and 50 epochs. Class weights 
were added to balance the biased proportion of positive and 
negative cases respectively for all four tasks. 
To validate the performance of the neural network for the 
classification tasks, cross validation was conducted 10 times 
by each randomly splitting data into training set and validation 
set at a ratio of 4:1. For patient clustering, all samples were 
used for neural network training. 
Post-classification analysis workflow 
Analysis after classification with multi-task neural network 
model includes three steps: (1) evaluating neural network clas-
sification performance; (2) clustering patients using values 
from the representation layer; and (3) profiling risk factors for 
in-hospital MACE in each patient cluster using the attention 
values. 
Patient clustering 
For each patient, values of the representation layer after train-
ing were used as the vector for clustering, which is a 32-
dimension vector. K-means was used for patient clustering. 
Model selection was conducted using Bayesian Information 
Criteria to choose model from a range of different K (number 
of clusters) settings (2 to 15). We selected K = 7 for K-means 
clustering. 
Implementation 
Cohort construction, feature construction and post-
classification analysis were conducted using R 3.4.1. Neural 
network training and analysis were conducted using Python 
2.7.14, Keras 2.2.4, and Theano 1.0.3. 
 
Results 
Neural network classification performance 
We used the multi-task neural network for the four selected 
classification tasks. Proportions of positive cases in four clas-
sification tasks are shown in Table 1, which are largely imbal-
anced. Classification performances are evaluated by AUROC 
(area under the receiver operating characteristics) and AUPRC 
(area under the precision recall curve) on the validation set in 
a cross validation setting (Table 1). From the results, MACE 
and antiplatelet treatment were best classified while beta-
blockers treatment has the lowest classification performance. 
The results suggest that the learned neural network model is a 
greater reflection of the patient states corresponding to MACE 
and antiplatelet treatment. 
Table 1 - Neural network classification performance 
Task 
Positive 
case 
Performance 
AUROC 
AUPRC 
(class 0) 
AUPRC 
(class 1) 
MACE 3.54% 
0.8602 
(0.0141) 
0.9926 
(0.0007) 
0.2924 
(0.0551) 
Antiplatelet 
treatment 
80.50% 
0.8634 
(0.0078) 
0.5799 
(0.0197) 
0.9640 
(0.0038) 
Beta-blockers 
treatment 
68.87% 
0.6881 
(0.0131) 
0.5035 
(0.0199) 
0.8184 
(0.0097) 
Statins 
treatment 
89.24% 
0.7725 
(0.0167) 
0.2842 
(0.0275) 
0.9635 
(0.0045) 
Note: In performance cells, the numbers denote mean value (standard 
deviation). 
 
K-means clustering 
K-means was conducted on the representation layer to cluster 
patients into seven groups. Clustering results are visualized in 
Figure 2, where t-SNE was conducted to reduce the 32-
dimension data in the representation layer to 2 dimensions and 
used color to denote the assigned cluster membership. We see 
clear separation of the clusters in the low dimension represen-
tation. 
 
Figure 2 - Visualization of patient clustering using t-SNE plot. 
 
Distribution of cluster size, and the properties relating to clas-
sification tasks are shown in Table 2. Clusters were organized 
based on descending MACE onset rate. The seven clusters 
have different cluster size, MACE rate and treatment rate. 
Cluster 2 has only 5 samples and is thus not included in later 
comparison. The largest cluster (9,889/26,986; 37%) had the 
highest MACE rate, and lower treatment rate compared to the 
overall cohort. 
Table 2 - Distribution of cluster size and classification labels 
 Size MACE 
Anti-
platelet 
treatment 
Beta-
blockers 
treatment 
Statins 
treatment 
Overall  
26,986 
(100%) 
955 
(3.5%) 
21,708 
(80.5%) 
18,572 
(68.9%) 
24,066 
(89.2%) 
Cluster 3 
9,889 
(37%) 
760 
(7.7%) 
7,768 
(78.6%) 
6,210 
(62.8%) 
8,496 
(85.9%) 
Cluster 4 
3,163 
(12%) 
74 
(2.3%) 
3,139 
(99.2%) 
2,361 
(74.6%) 
3,064 
(96.9%) 
Cluster 1 
4,353 
(16%) 
82 
(1.9%) 
4,346 
(99.8%) 
3,225 
(74.1%) 
4,284 
(98.4%) 
Cluster 7 
2,709 
(10%) 
23 
(0.8%) 
2,708 
(100.0%) 
2,292 
(84.6%) 
2,690 
(99.3%) 
Cluster 6 
3,212 
(12%) 
14 
(0.4%) 
1,119 
(34.8%) 
1,788 
(55.7%) 
2,214 
(68.9%) 
Cluster 5 
3,637 
(13%) 
2 
(0.1%) 
2,623 
(72.1%) 
2,691 
(74.0%) 
3,313 
(91.1%) 
Cluster 2 
5 
(0%) 
0 
(0.0%) 
5 
(100.0%) 
5 
(100.0%) 
5 
(100.0%) 
Note: In each cell, the numbers denote count (proportion). In column 
‘Size’, the proportion is the proportion in the overall patient cohort. 
In other columns, the proportion is the proportion in the specified 
cluster. 
 
Profiles of patient clusters were analyzed. Notable features of 
each patient cluster are presented in Table 3. Specifically, 
Cluster 3 has more severe conditions as is shown by the high-
est average age, proportion of patients with elevated cardiac 
enzyme levels, and the lowest average left ventricular ejection 
fraction (LVEF [%]). Cluster 4 also has comparatively severe 
condition as is shown by the Killip class. Cluster 1 does not 
show severe disease, but the MACE rate is still high, which is 
potentially associated with bad living habits (highest propor-
tion of current smoker and current alcohol drinker) of this 
cluster. Cluster 7 is featured by the highest proportion of 
STEMI patients and lowest proportion of UA patients. Though 
STEMI patients are far more prone to in-hospital MACE 
compared to UA and NSTEMI, this cluster is not associated 
with a high MACE rate, potentially as a combined effect of 
the less complicated disease manifestation and the high level 
of treatment. Cluster 6 has the highest proportion of UA pa-
tients, and are less prone to MACE even though they have the 
lowest treatment rates. Cluster 5 is featured by the low disease 
severity, and correspondingly, the lowest MACE rate. 
Risk factors for MACE in each patient cluster 
For each patient, a feature’s attention value for the MACE 
classification task from the neural network is used as its im-
portance in predicting MACE. For each patient cluster, a fea-
ture’s importance is calculated as the average attention value 
of all patients in the cluster. Feature importance in each pa-
tient cluster is shown in Table 4. Features with different im-
portance or high clinical relevance are selectively listed. The 
largest value in each row is shown in bold. Different clusters 
have different feature importance, indicating different risk 
profiles. As an example, smoking is a more important risk 
factor for MACE in Cluster 1 and Cluster 7, current comorbid-
ity of hypertension more important for Cluster 4, 5 and 6, age 
and systolic blood pressure are more important in Cluster 3 
than in other clusters. 
Table 3. Profile of patient clusters 
Cluster Has the highest Has the lowest 
3 
MACE rate 
Age 
Proportion of NSTEMI patients 
Cormobidity of  atrial 
fibrillation 
Elevated cardiac enzyme levels 
LVEF (%) 
4 
Killip class 
History of myocardial 
infarction 
 
1 
Current smoker and current 
alcohol drinker 
 
7 
Antiplatelet treatment 
Beta-blockers treatment 
Statins treatment 
Proportion of STEMI patients 
Proportion of UA 
patients 
Killip class 
Proportion of patients 
with cormorbidity 
Proportion of patients 
with disease history 
6 
Proportion of female patients 
Proportion of UA patients 
Antiplatelet treatment 
Beta-blockers 
treatment 
Statins treatment 
5 
LVEF (%) 
Cormobidity of hypertension 
History of vascular disease 
History of established coronary 
artery disease 
History of percutaneous 
coronary intervention 
History of coronary artery 
bypass grafting 
History of other conditions 
confirmed by  computed 
tomography angiography 
MACE rate 
Elevated enzyme levels 
Discussion 
Attention mechanism and feature importance. Attention 
model in neural network is inspired by brain’s neural mecha-
nism of attention and is simplified here as: in each sample, 
including a numerical weight (‘attention value’) for each pre-
dictor associated with each outcome. When we normalize the 
weights for each sample to be all larger than 0 and have a sum 
of 1, the attention values look similar to a probability distribu-
tion to show the feature importance. In our study, we consider 
the outcome of in-hospital MACE. For each feature, we calcu-
late the average attention value of patients in a cluster and use 
it as its importance in this cluster. When a feature has an im-
portance larger than 0, we regard it as a risk factor to the out-
come, where the feature importance is taken as the importance 
of the risk factor. The attention mechanism makes the neural 
network models, otherwise ‘black boxes’, interpretable to 
some degree, but is still less clear compared to logistic regres-
sion models, where both the feature importance and the action 
directionality (positive or negative impact) are shown with 
odds ratio, confidence intervals, and coefficient p-values. 
Choice of outcomes. Multi-task learning is an approach to 
transfer domain knowledge contained in related outcomes and 
learn in paralleled using a shared representation [21]. The in-
centive for the approach is that the outcomes are reflections of 
different facets of a common latent representation. To better 
know the latent representation, we learn from different out-
comes. When thinking of the patient state as the latent repre-
sentation, we need to choose outcomes that are reflections of 
the patient state. In our study, antiplatelet, beta-blockers, and 
statins treatment are prescribed based on doctors’ perception 
of the patient based on domain knowledge. MACE outcome is 
a direct result of the patient disease state. We thus include all 
four outcomes to better represent the patient. After assessing 
the classification performance, the patient representation bet-
ter characterizes the patient state regarding MACE and an-
tiplatelet treatment than the patient state regarding beta-
blocker treatment. 
Table 4.Feature importance in each patient cluster 
Cluster 3 4 1 7 6 5 
Ethnic group 
(Han) 
0.046  0.070  0.048  0.050  0.127  0.088  
ACS Type 
(NSTEMI) 
0.029  0.015  0.030  0.039  0.016  0.008  
ACS Type 
(STEMI) 
0.002  0.002  0.003  0.003  0.002  0.002  
ACS Type 
(UA) 
0.085  0.134  0.059  0.045  0.138  0.208  
Current smok-
ing 
0.046  0.052  0.091  0.095  0.032  0.030  
Current Hy-
pertension 
0.032  0.103  0.036  0.033  0.127  0.146  
Current Diabe-
tes 
0.032  0.033  0.053  0.034  0.034  0.028  
Current atrial 
fibrillation  
0.082  0.055  0.078  0.085  0.056  0.025  
Current Percu-
taneous coro-
nary interven-
tion 
0.064  0.071  0.101  0.086  0.018  0.032  
Elevated en-
zyme levels 
0.047  0.043  0.050  0.060  0.080  0.061  
Killip Class 0.048  0.029  0.035  0.036  0.005  0.011  
Age (years) 0.045  0.029  0.033  0.027  0.008  0.013  
Systolic blood 
pressure 
(mmHg) 
0.033  0.017  0.018  0.019  0.010  0.012  
White blood 
cell count 
(×10^9/L) 
0.029  0.031  0.020  0.020  0.019  0.029  
 
Pitfalls in interpretation of the results. Two points need to 
be addressed regarding interpretation of the results. First, algo-
rithmically meaningful clusters are not necessarily clinically 
meaningful clusters. Though the clustering result has implica-
tion for disease prognosis, whether it can inform clinical prac-
tice needs further clinical research. Second, risk factors cannot 
be directly translated to clinical intervention. As an example, 
though comorbidity of hypertension and high systolic blood 
pressure are risk factors for in-hospital MACE, the results are 
not sufficient to claim the intensity of hypertension treatment 
required for different clusters. 
Suggestions for future study. Our suggestions for future 
study using similar approach include: (1) carefully select clin-
ically meaningful outcomes to be used; (2) use fewer features 
and easily acquired ones would make the results more appli-
cable; and (3) identify cluster-specific interventions consider-
ing treatment effectiveness would add extra clinical value to 
similar studies. 
Conclusions 
In this study, we used multi-task neural network with attention 
as a modeling framework to support learning of patient state 
representations, cluster analysis of patients, and profiling of 
feature importance. Seven patient clusters were discovered, 
which have different characteristics and risk profile to in-
hospital MACE. The results demonstrate cluster analysis using 
outcome-driven multi-task neural network as a promising ap-
proach for ACS patient classification and subtyping. 
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